REFERENCES
- Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006;92:987–993.
- Li D, Keffer J, Corry K, Vazquez M, Jialal I. Nonspecific elevation of troponin T levels in patients with chronic renal failure. Clin Biochem. 1995;28:474–477.
- De Zoysa JR. Cardiac troponins and renal disease. Nephrology. 2004;9:83–88.
- Ooi DS, Veinot JP, Wells GA, House AA. Increased mortality in hemodialyzed patients with elevated serum troponin T: One-year outcome study. Clin Biochem. 1999;32:647–652.
- Dierkes J, Domrose U, Westphal S, . Cardiac troponins predicts mortality in patients with end-stage renal disease. Circulation. 2000;102:1964–1969.
- Apple FS, Marakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106:2941–2945.
- Collinson PO, Hadcocks L, Foo Y, . Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem. 1998;35:380–386.
- Collison PO, Stubbs PJ. Are troponins confusing? Heart. 2003;89:1285–1287.
- Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8:R204–R212.
- Architect STAT troponin-I. Package insert, Cat. Log no. 840549/R6. Chicago, IL: Abbott Laboratories; 2008.
- Troponin T Roche diagnostic package insert, 2007-09 V4 English. Mannhiem: Roche Diagnostics GmbH, 2007–2009.
- Hickman PE, Koerbin G, Southcott E, Tate J. Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease. Ann Clin Biochem. 2007;44:285–289.
- Apple FS, Wu AH, Jaffe AS. European society of cardiology and American college of cardiology guideline for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J. 2002;144:981–986.
- Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AH, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem. 2005;51:2198–2200.
- Jeon DS, Lee MY, Kim CJ, . Clinical findings in patients with cardiac troponin T elevation and end-stage renal disease without acute coronary syndrome. Am J Cardiol. 2004;94:831–834.
- Aksoy N, Ozer O, Sari I, Sucu M, Aksoy M, Geyikli I. Contribution of renal function impairment to unexplained troponin T elevation in congestive heart failure. Ren Fail. 2009;31:272–277.
- Tsutamoto T, Kawahara C, Yamaji M, . Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. Eur J Heart Fail. 2009;11:653–658.
- Ellis K, Dreisbach AW, Lertora JJ. Plasma elimination of cardiac troponin in end-stage renal disease. South Med J. 2001;94:993–996.
- Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial infarction. J Am Coll Cardiol. 2009;54:1165–1172.
- Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP. Impaired renal clearance explains troponin T fragments in hemodialysis patients. Circulation. 2004;109:23–25.